Global Osimertinib Drugs Market Research Report 2023
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
According to QYResearch’s new survey, global Osimertinib Drugs market is projected to reach US$ 10160 million in 2029, increasing from US$ 5653.5 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osimertinib Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Osimertinib Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Osimertinib Drugs market is projected to reach US$ 10160 million in 2029, increasing from US$ 5653.5 million in 2022, with the CAGR of 8.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Osimertinib Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Osimertinib Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AstraZeneca
- 40mg
- 80mg
- Hospital
- Drugs Store
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 OSIMERTINIB DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Osimertinib Drugs
1.2 Osimertinib Drugs Segment by Type
1.2.1 Global Osimertinib Drugs Market Value Comparison by Type (2023-2029)
1.2.2 40mg
1.2.3 80mg
1.3 Osimertinib Drugs Segment by Application
1.3.1 Global Osimertinib Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Osimertinib Drugs Market Size Estimates and Forecasts
1.4.1 Global Osimertinib Drugs Revenue 2018-2029
1.4.2 Global Osimertinib Drugs Sales 2018-2029
1.4.3 Global Osimertinib Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 OSIMERTINIB DRUGS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Osimertinib Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Osimertinib Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Osimertinib Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Osimertinib Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Osimertinib Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Osimertinib Drugs, Product Type & Application
2.7 Osimertinib Drugs Market Competitive Situation and Trends
2.7.1 Osimertinib Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Osimertinib Drugs Players Market Share by Revenue
2.7.3 Global Osimertinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OSIMERTINIB DRUGS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Osimertinib Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Osimertinib Drugs Global Osimertinib Drugs Sales by Region: 2018-2029
3.2.1 Global Osimertinib Drugs Sales by Region: 2018-2023
3.2.2 Global Osimertinib Drugs Sales by Region: 2024-2029
3.3 Global Osimertinib Drugs Global Osimertinib Drugs Revenue by Region: 2018-2029
3.3.1 Global Osimertinib Drugs Revenue by Region: 2018-2023
3.3.2 Global Osimertinib Drugs Revenue by Region: 2024-2029
3.4 North America Osimertinib Drugs Market Facts & Figures by Country
3.4.1 North America Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Osimertinib Drugs Sales by Country (2018-2029)
3.4.3 North America Osimertinib Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Osimertinib Drugs Market Facts & Figures by Country
3.5.1 Europe Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Osimertinib Drugs Sales by Country (2018-2029)
3.5.3 Europe Osimertinib Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Osimertinib Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Osimertinib Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Osimertinib Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Osimertinib Drugs Market Facts & Figures by Country
3.7.1 Latin America Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Osimertinib Drugs Sales by Country (2018-2029)
3.7.3 Latin America Osimertinib Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Osimertinib Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Osimertinib Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Osimertinib Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Osimertinib Drugs Sales by Type (2018-2029)
4.1.1 Global Osimertinib Drugs Sales by Type (2018-2023)
4.1.2 Global Osimertinib Drugs Sales by Type (2024-2029)
4.1.3 Global Osimertinib Drugs Sales Market Share by Type (2018-2029)
4.2 Global Osimertinib Drugs Revenue by Type (2018-2029)
4.2.1 Global Osimertinib Drugs Revenue by Type (2018-2023)
4.2.2 Global Osimertinib Drugs Revenue by Type (2024-2029)
4.2.3 Global Osimertinib Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Osimertinib Drugs Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Osimertinib Drugs Sales by Application (2018-2029)
5.1.1 Global Osimertinib Drugs Sales by Application (2018-2023)
5.1.2 Global Osimertinib Drugs Sales by Application (2024-2029)
5.1.3 Global Osimertinib Drugs Sales Market Share by Application (2018-2029)
5.2 Global Osimertinib Drugs Revenue by Application (2018-2029)
5.2.1 Global Osimertinib Drugs Revenue by Application (2018-2023)
5.2.2 Global Osimertinib Drugs Revenue by Application (2024-2029)
5.2.3 Global Osimertinib Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Osimertinib Drugs Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Osimertinib Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Osimertinib Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Osimertinib Drugs Industry Chain Analysis
7.2 Osimertinib Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Osimertinib Drugs Production Mode & Process
7.4 Osimertinib Drugs Sales and Marketing
7.4.1 Osimertinib Drugs Sales Channels
7.4.2 Osimertinib Drugs Distributors
7.5 Osimertinib Drugs Customers
8 OSIMERTINIB DRUGS MARKET DYNAMICS
8.1 Osimertinib Drugs Industry Trends
8.2 Osimertinib Drugs Market Drivers
8.3 Osimertinib Drugs Market Challenges
8.4 Osimertinib Drugs Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Osimertinib Drugs
1.2 Osimertinib Drugs Segment by Type
1.2.1 Global Osimertinib Drugs Market Value Comparison by Type (2023-2029)
1.2.2 40mg
1.2.3 80mg
1.3 Osimertinib Drugs Segment by Application
1.3.1 Global Osimertinib Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Osimertinib Drugs Market Size Estimates and Forecasts
1.4.1 Global Osimertinib Drugs Revenue 2018-2029
1.4.2 Global Osimertinib Drugs Sales 2018-2029
1.4.3 Global Osimertinib Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 OSIMERTINIB DRUGS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Osimertinib Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Osimertinib Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Osimertinib Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Osimertinib Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Osimertinib Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Osimertinib Drugs, Product Type & Application
2.7 Osimertinib Drugs Market Competitive Situation and Trends
2.7.1 Osimertinib Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Osimertinib Drugs Players Market Share by Revenue
2.7.3 Global Osimertinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OSIMERTINIB DRUGS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Osimertinib Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Osimertinib Drugs Global Osimertinib Drugs Sales by Region: 2018-2029
3.2.1 Global Osimertinib Drugs Sales by Region: 2018-2023
3.2.2 Global Osimertinib Drugs Sales by Region: 2024-2029
3.3 Global Osimertinib Drugs Global Osimertinib Drugs Revenue by Region: 2018-2029
3.3.1 Global Osimertinib Drugs Revenue by Region: 2018-2023
3.3.2 Global Osimertinib Drugs Revenue by Region: 2024-2029
3.4 North America Osimertinib Drugs Market Facts & Figures by Country
3.4.1 North America Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Osimertinib Drugs Sales by Country (2018-2029)
3.4.3 North America Osimertinib Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Osimertinib Drugs Market Facts & Figures by Country
3.5.1 Europe Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Osimertinib Drugs Sales by Country (2018-2029)
3.5.3 Europe Osimertinib Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Osimertinib Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Osimertinib Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Osimertinib Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Osimertinib Drugs Market Facts & Figures by Country
3.7.1 Latin America Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Osimertinib Drugs Sales by Country (2018-2029)
3.7.3 Latin America Osimertinib Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Osimertinib Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Osimertinib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Osimertinib Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Osimertinib Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Osimertinib Drugs Sales by Type (2018-2029)
4.1.1 Global Osimertinib Drugs Sales by Type (2018-2023)
4.1.2 Global Osimertinib Drugs Sales by Type (2024-2029)
4.1.3 Global Osimertinib Drugs Sales Market Share by Type (2018-2029)
4.2 Global Osimertinib Drugs Revenue by Type (2018-2029)
4.2.1 Global Osimertinib Drugs Revenue by Type (2018-2023)
4.2.2 Global Osimertinib Drugs Revenue by Type (2024-2029)
4.2.3 Global Osimertinib Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Osimertinib Drugs Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Osimertinib Drugs Sales by Application (2018-2029)
5.1.1 Global Osimertinib Drugs Sales by Application (2018-2023)
5.1.2 Global Osimertinib Drugs Sales by Application (2024-2029)
5.1.3 Global Osimertinib Drugs Sales Market Share by Application (2018-2029)
5.2 Global Osimertinib Drugs Revenue by Application (2018-2029)
5.2.1 Global Osimertinib Drugs Revenue by Application (2018-2023)
5.2.2 Global Osimertinib Drugs Revenue by Application (2024-2029)
5.2.3 Global Osimertinib Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Osimertinib Drugs Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Osimertinib Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Osimertinib Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Osimertinib Drugs Industry Chain Analysis
7.2 Osimertinib Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Osimertinib Drugs Production Mode & Process
7.4 Osimertinib Drugs Sales and Marketing
7.4.1 Osimertinib Drugs Sales Channels
7.4.2 Osimertinib Drugs Distributors
7.5 Osimertinib Drugs Customers
8 OSIMERTINIB DRUGS MARKET DYNAMICS
8.1 Osimertinib Drugs Industry Trends
8.2 Osimertinib Drugs Market Drivers
8.3 Osimertinib Drugs Market Challenges
8.4 Osimertinib Drugs Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Osimertinib Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Osimertinib Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Osimertinib Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Osimertinib Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Osimertinib Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Osimertinib Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Osimertinib Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Osimertinib Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Osimertinib Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Osimertinib Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Osimertinib Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Osimertinib Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osimertinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osimertinib Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Osimertinib Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Osimertinib Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Osimertinib Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Osimertinib Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Osimertinib Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Osimertinib Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Osimertinib Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Osimertinib Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Osimertinib Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Osimertinib Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Osimertinib Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Osimertinib Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Osimertinib Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Osimertinib Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Osimertinib Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Osimertinib Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Osimertinib Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Osimertinib Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Osimertinib Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Osimertinib Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Osimertinib Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Osimertinib Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Osimertinib Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Osimertinib Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Osimertinib Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Osimertinib Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Osimertinib Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Osimertinib Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Osimertinib Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Osimertinib Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Osimertinib Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Osimertinib Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Osimertinib Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Osimertinib Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Osimertinib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AstraZeneca Osimertinib Drugs Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Osimertinib Drugs Distributors List
Table 78. Osimertinib Drugs Customers List
Table 79. Osimertinib Drugs Market Trends
Table 80. Osimertinib Drugs Market Drivers
Table 81. Osimertinib Drugs Market Challenges
Table 82. Osimertinib Drugs Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 1. Global Osimertinib Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Osimertinib Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Osimertinib Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Osimertinib Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Osimertinib Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Osimertinib Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Osimertinib Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Osimertinib Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Osimertinib Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Osimertinib Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Osimertinib Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Osimertinib Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osimertinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osimertinib Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Osimertinib Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Osimertinib Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Osimertinib Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Osimertinib Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Osimertinib Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Osimertinib Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Osimertinib Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Osimertinib Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Osimertinib Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Osimertinib Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Osimertinib Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Osimertinib Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Osimertinib Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Osimertinib Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Osimertinib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Osimertinib Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Osimertinib Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Osimertinib Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Osimertinib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Osimertinib Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Osimertinib Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Osimertinib Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Osimertinib Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Osimertinib Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Osimertinib Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Osimertinib Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Osimertinib Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Osimertinib Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Osimertinib Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Osimertinib Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Osimertinib Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Osimertinib Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Osimertinib Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Osimertinib Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Osimertinib Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Osimertinib Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Osimertinib Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Osimertinib Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Osimertinib Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Osimertinib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AstraZeneca Osimertinib Drugs Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Osimertinib Drugs Distributors List
Table 78. Osimertinib Drugs Customers List
Table 79. Osimertinib Drugs Market Trends
Table 80. Osimertinib Drugs Market Drivers
Table 81. Osimertinib Drugs Market Challenges
Table 82. Osimertinib Drugs Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Osimertinib Drugs
Figure 2. Global Osimertinib Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Osimertinib Drugs Market Share by Type in 2022 & 2029
Figure 4. 40mg Product Picture
Figure 5. 80mg Product Picture
Figure 6. Global Osimertinib Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Osimertinib Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Global Osimertinib Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Osimertinib Drugs Market Size (2018-2029) & (US$ Million)
Figure 12. Global Osimertinib Drugs Sales (2018-2029) & (K Units)
Figure 13. Global Osimertinib Drugs Average Price (US$/Unit) & (2018-2029)
Figure 14. Osimertinib Drugs Report Years Considered
Figure 15. Osimertinib Drugs Sales Share by Manufacturers in 2022
Figure 16. Global Osimertinib Drugs Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Osimertinib Drugs Players: Market Share by Revenue in 2022
Figure 18. Osimertinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Osimertinib Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 21. North America Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 22. United States Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 25. Europe Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 26. Germany Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Osimertinib Drugs Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Osimertinib Drugs Revenue Market Share by Region (2018-2029)
Figure 33. China Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 43. Latin America Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Osimertinib Drugs by Type (2018-2029)
Figure 53. Global Revenue Market Share of Osimertinib Drugs by Type (2018-2029)
Figure 54. Global Osimertinib Drugs Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Osimertinib Drugs by Application (2018-2029)
Figure 56. Global Revenue Market Share of Osimertinib Drugs by Application (2018-2029)
Figure 57. Global Osimertinib Drugs Price (US$/Unit) by Application (2018-2029)
Figure 58. Osimertinib Drugs Value Chain
Figure 59. Osimertinib Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Osimertinib Drugs
Figure 2. Global Osimertinib Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Osimertinib Drugs Market Share by Type in 2022 & 2029
Figure 4. 40mg Product Picture
Figure 5. 80mg Product Picture
Figure 6. Global Osimertinib Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Osimertinib Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Global Osimertinib Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Osimertinib Drugs Market Size (2018-2029) & (US$ Million)
Figure 12. Global Osimertinib Drugs Sales (2018-2029) & (K Units)
Figure 13. Global Osimertinib Drugs Average Price (US$/Unit) & (2018-2029)
Figure 14. Osimertinib Drugs Report Years Considered
Figure 15. Osimertinib Drugs Sales Share by Manufacturers in 2022
Figure 16. Global Osimertinib Drugs Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Osimertinib Drugs Players: Market Share by Revenue in 2022
Figure 18. Osimertinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Osimertinib Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 21. North America Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 22. United States Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 25. Europe Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 26. Germany Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Osimertinib Drugs Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Osimertinib Drugs Revenue Market Share by Region (2018-2029)
Figure 33. China Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 43. Latin America Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Osimertinib Drugs Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Osimertinib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Osimertinib Drugs by Type (2018-2029)
Figure 53. Global Revenue Market Share of Osimertinib Drugs by Type (2018-2029)
Figure 54. Global Osimertinib Drugs Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Osimertinib Drugs by Application (2018-2029)
Figure 56. Global Revenue Market Share of Osimertinib Drugs by Application (2018-2029)
Figure 57. Global Osimertinib Drugs Price (US$/Unit) by Application (2018-2029)
Figure 58. Osimertinib Drugs Value Chain
Figure 59. Osimertinib Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
